Team Rapid Novor will be attending PEGS Europe, 12 -16 November 2018, Lisbon Congress Center, Lisbon, Portugal. Booth #208
Our co-founder and CEO, Mingjie, will speak at the conference. He will talk about the goal, the challenges and our REmAb™ approach towards antibody protein sequencing. We have recently accelerated our sequencing project delivery timeline and reduced the amount of mAb protein samples required for the sequencing work. Mingjie will share in greater details the experiences and best practices we developed to make those advancement possible. We invite you to attend his talk and connect with us at our booth #208.
The team will be travelling in Switzerland, The Netherlands, Germany, France to meet customers before the conference. We’d love to meet you in person. Please drop us an email at sales@rapidnovor.com and we will contact you to book a meeting.
Talk to Our Scientists.
We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.
Talk to Our Scientists.
We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics